---
date: 2021-08-27
title: vaccine phase 3 
categories: sante
---

[Nature](https://www.nature.com/articles/s41591-021-01230-y), [DOI](https://doi.org/10.1038/s41591-021-01230-y)

However, there is a cautionary tale in the deployment of a dengue vaccine where more severe dengue virus disease was seen in a subset of recipients as protective, vaccine-associated antibody decreased.51 A final potential concern comes from multi-system inflammatory syndrome in children (MIS-C) who are infected with COVID-19; some have warned that the occurrence of MIS-C should be carefully monitored after COVID-19 vaccination becomes widespread